Takashi Ogura


Ontology type: schema:Person     


Person Info

NAME

Takashi

SURNAME

Ogura

Publications in SciGraph latest 50 shown

  • 2022-08-22 The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force in NATURE COMMUNICATIONS
  • 2022-08-08 DOCK2 is involved in the host genetics and biology of severe COVID-19 in NATURE
  • 2022-03-16 Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis in HEART AND VESSELS
  • 2022-03-04 The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: “hexagonal pattern”: a single-center retrospective study in BMC PULMONARY MEDICINE
  • 2022-03 Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers in TARGETED ONCOLOGY
  • 2022-01-27 Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse parenchymal lung disease in BMC PULMONARY MEDICINE
  • 2021-10-19 Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach in SCIENTIFIC REPORTS
  • 2021-08-27 Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial in INFECTIOUS DISEASES AND THERAPY
  • 2021-07-30 A proposed prognostic prediction score for pleuroparenchymal fibroelastosis in RESPIRATORY RESEARCH
  • 2021-05-21 Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study in SCIENTIFIC REPORTS
  • 2021-01-27 Pulmonary vascular enlargement and lesion extent on computed tomography are correlated with COVID-19 disease severity in JAPANESE JOURNAL OF RADIOLOGY
  • 2021-01-24 Coronary artery disease and heart failure in patients with idiopathic pulmonary fibrosis in HEART AND VESSELS
  • 2020-12-01 A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19 in SCIENTIFIC REPORTS
  • 2020-11-30 Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan in RESPIRATORY RESEARCH
  • 2020-10-28 Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease in THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
  • 2020-10-23 Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy in BMC PULMONARY MEDICINE
  • 2020-10-14 A case report of idiopathic pleuroparenchymal fibroelastosis with severe respiratory failure in pregnancy in BMC PULMONARY MEDICINE
  • 2020-08-12 Relationship of flow-volume curve pattern on pulmonary function test with clinical and radiological features in idiopathic pulmonary fibrosis in BMC PULMONARY MEDICINE
  • 2020-07-29 In reply in JAPANESE JOURNAL OF RADIOLOGY
  • 2020-06-13 Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study) in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2020-04-22 Correction to: Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia in JAPANESE JOURNAL OF RADIOLOGY
  • 2020-03-31 Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia in JAPANESE JOURNAL OF RADIOLOGY
  • 2020-02-26 High-resolution CT features distinguishing usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis from those with idiopathic pulmonary fibrosis in JAPANESE JOURNAL OF RADIOLOGY
  • 2019-09-10 Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy in ESOPHAGUS
  • 2019-06-11 Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1 in RESPIRATORY RESEARCH
  • 2019-06-09 Histology for Transbronchial Lung Cryobiopsy Samples in TRANSBRONCHIAL CRYOBIOPSY IN DIFFUSE PARENCHYMAL LUNG DISEASE
  • 2019-04-24 Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer in INVESTIGATIONAL NEW DRUGS
  • 2019-04-11 Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis in BMC PULMONARY MEDICINE
  • 2019-03-07 The upward shift of hilar structures and tracheal deviation in pleuroparenchymal fibroelastosis in MULTIDISCIPLINARY RESPIRATORY MEDICINE
  • 2018-03-02 Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016 in BMC CANCER
  • 2018-01-30 Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy? in BMC PULMONARY MEDICINE
  • 2017-12-15 Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings in JAPANESE JOURNAL OF RADIOLOGY
  • 2017-11-28 Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status in BMC CANCER
  • 2017-09-21 Extraction of the subpleural lung region from computed tomography images to detect interstitial lung disease in JAPANESE JOURNAL OF RADIOLOGY
  • 2017-09-07 Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis in SCIENTIFIC REPORTS
  • 2017-05-26 Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604 in BMC CANCER
  • 2016-12-01 Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy in BMC PULMONARY MEDICINE
  • 2016-04-29 Safety and efficacy of S-1 in combination with carboplatin in non-small cell lung cancer patients with interstitial lung disease: a pilot study in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016-04-29 Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens in SUPPORTIVE CARE IN CANCER
  • 2016-03-03 Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report in BMC PULMONARY MEDICINE
  • 2015-11-06 Multicenter study of quantitative computed tomography analysis using a computer-aided three-dimensional system in patients with idiopathic pulmonary fibrosis in JAPANESE JOURNAL OF RADIOLOGY
  • 2015-04-23 Erratum to: Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy in MEDICAL ONCOLOGY
  • 2015-02-11 Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease in JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE
  • 2014-09-11 Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy in MEDICAL ONCOLOGY
  • 2014-09 Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs in THERAPEUTIC INNOVATION & REGULATORY SCIENCE
  • 2014-06-28 An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features in BMC PULMONARY MEDICINE
  • 2012-03-06 Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity in ARTHRITIS RESEARCH & THERAPY
  • 2011-12-01 Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment in RESPIRATORY RESEARCH
  • 2011-12-01 The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial in RESPIRATORY RESEARCH
  • 2011-08-07 Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality in EUROPEAN RADIOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.419708.3", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.470350.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.490702.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.264706.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412764.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.497282.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267335.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.272242.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414944.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415479.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416203.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17063.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417184.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415740.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.258333.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.482503.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419430.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415270.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410786.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417366.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.45203.30", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.268441.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.265061.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415797.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.136304.3", 
            "type": "Organization"
          }
        ], 
        "familyName": "Ogura", 
        "givenName": "Takashi", 
        "id": "sg:person.07607304512.39", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-6326-9993"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07607304512.39", 
          "https://orcid.org/0000-0002-6326-9993"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-12-01T07:12", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/person/person_638.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.07607304512.39'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.07607304512.39'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.07607304512.39'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.07607304512.39'


     

    This table displays all metadata directly associated to this object as RDF triples.

    69 TRIPLES      11 PREDICATES      37 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.07607304512.39 schema:affiliation Nb01dd7c0230344ccac54219c4262181a
    2 grid-institutes:grid.136304.3
    3 grid-institutes:grid.17063.33
    4 grid-institutes:grid.258333.c
    5 grid-institutes:grid.264706.1
    6 grid-institutes:grid.265061.6
    7 grid-institutes:grid.267335.6
    8 grid-institutes:grid.268441.d
    9 grid-institutes:grid.272242.3
    10 grid-institutes:grid.410786.c
    11 grid-institutes:grid.412764.2
    12 grid-institutes:grid.414944.8
    13 grid-institutes:grid.415270.5
    14 grid-institutes:grid.415479.a
    15 grid-institutes:grid.415740.3
    16 grid-institutes:grid.415797.9
    17 grid-institutes:grid.416203.2
    18 grid-institutes:grid.417184.f
    19 grid-institutes:grid.417366.1
    20 grid-institutes:grid.419430.b
    21 grid-institutes:grid.45203.30
    22 grid-institutes:grid.470350.5
    23 grid-institutes:grid.482503.8
    24 grid-institutes:grid.490702.8
    25 grid-institutes:grid.497282.2
    26 schema:familyName Ogura
    27 schema:givenName Takashi
    28 schema:identifier Nd5cd4b01a4f94057bdd0dc38208de4c0
    29 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07607304512.39
    30 https://orcid.org/0000-0002-6326-9993
    31 schema:sdDatePublished 2022-12-01T07:12
    32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    33 schema:sdPublisher Nae99d48d200c4c68b0ee385faf1f59ce
    34 sgo:license sg:explorer/license/
    35 sgo:sdDataset persons
    36 rdf:type schema:Person
    37 Nae99d48d200c4c68b0ee385faf1f59ce schema:name Springer Nature - SN SciGraph project
    38 rdf:type schema:Organization
    39 Nb01dd7c0230344ccac54219c4262181a schema:affiliation grid-institutes:grid.419708.3
    40 sgo:isCurrent true
    41 rdf:type schema:OrganizationRole
    42 Nd5cd4b01a4f94057bdd0dc38208de4c0 schema:name orcid_id
    43 schema:value 0000-0002-6326-9993
    44 rdf:type schema:PropertyValue
    45 grid-institutes:grid.136304.3 schema:Organization
    46 grid-institutes:grid.17063.33 schema:Organization
    47 grid-institutes:grid.258333.c schema:Organization
    48 grid-institutes:grid.264706.1 schema:Organization
    49 grid-institutes:grid.265061.6 schema:Organization
    50 grid-institutes:grid.267335.6 schema:Organization
    51 grid-institutes:grid.268441.d schema:Organization
    52 grid-institutes:grid.272242.3 schema:Organization
    53 grid-institutes:grid.410786.c schema:Organization
    54 grid-institutes:grid.412764.2 schema:Organization
    55 grid-institutes:grid.414944.8 schema:Organization
    56 grid-institutes:grid.415270.5 schema:Organization
    57 grid-institutes:grid.415479.a schema:Organization
    58 grid-institutes:grid.415740.3 schema:Organization
    59 grid-institutes:grid.415797.9 schema:Organization
    60 grid-institutes:grid.416203.2 schema:Organization
    61 grid-institutes:grid.417184.f schema:Organization
    62 grid-institutes:grid.417366.1 schema:Organization
    63 grid-institutes:grid.419430.b schema:Organization
    64 grid-institutes:grid.419708.3 schema:Organization
    65 grid-institutes:grid.45203.30 schema:Organization
    66 grid-institutes:grid.470350.5 schema:Organization
    67 grid-institutes:grid.482503.8 schema:Organization
    68 grid-institutes:grid.490702.8 schema:Organization
    69 grid-institutes:grid.497282.2 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...